Kirtana Vedire

Kirtana Vedire

About

Detail

Chief Operating Officer
United States

Timeline


work
Job
school
Education

Résumé


Jobs verified_user 0% verified
  • Sevaro
    Chief Operating Officer
    Sevaro
    Jun 2025 - Current (1 year 5 months)
  • Sevaro
    Vice President of Operations
    Sevaro
    Jun 2024 - Jun 2025 (1 year 1 month)
  • Sevaro
    Director of Operations
    Sevaro
    May 2023 - Jun 2024 (1 year 2 months)
  • D
    Product Lead
    Dntl Bar
    May 2022 - Feb 2023 (10 months)
  • DSO Strategy LLC
    Chief Of Staff
    DSO Strategy LLC
    Mar 2022 - Feb 2023 (1 year)
  • MB Dental
    Dentist
    MB Dental
    Aug 2021 - Jun 2022 (11 months)
  • VideaHealth
    Dental Consultant
    VideaHealth
    Jul 2021 - Jan 2022 (7 months)
  • Overjet
    Dental Consultant - Machine Learning
    Overjet
    Oct 2019 - Apr 2020 (7 months)
  • SHYFT Analytics
    Solution Analyst
    SHYFT Analytics
    Jun 2016 - Jul 2017 (1 year 2 months)
  • Veterans Affairs Hospital
    Healthcare Analyst - Telemedicine
    Veterans Affairs Hospital
    Jan 2013 - Jan 2015 (2 years 1 month)
Education verified_user 0% verified
  • University of Washington
    Bachelor’s Degree, Molecular Biology
    University of Washington
    Jan 2011 - Jan 2014 (3 years 1 month)
  • Tufts University School of Medicine
    Doctor of Dental Medicine
    Tufts University School of Medicine
Publications verified_user 0% verified
  • J
    Teledermatology-Directed Surgical Care is Safe and Reduces Travel
    Jun
    Abstract

    Methods
    We conducted a retrospective chart review and identified 186 Veterans in the VA Corporate Data Warehouse as having malignant melanomas or severely dysplastic nevi during the four-year period of observation from 1 July 2009 to 30 June 2013 and met inclusion and exclusion criteria for analysis.

    Results
    Three hundred and sixty-six surgical procedures were performed for diagnosis and treatment of these conditions including biopsy and wide-local excision, of which 189 carefully selected cases were performed by primary care clinicians with 2.0% biopsy complication rate and a 7.7% wide-local excision complication rate. Cases not performed by primary care providers were referred to specialists (e.g
  • J
    Tumor Paint
    Jan
This is a community-created genome.